February 17, 2022

Djibouti launch final implementation of National Development Plan for 2020-2024: “Djibouti ICI”

Published by
TDPel Media

On February 13, Djibouti has launched the final implementation of the National Development Plan (NDP) for the period 2020-2024: “Djibouti ICI”. This is a particularly ambitious plan, based on three strategic axes: Inclusion – Connectivity – Institutions. A plan that fits into the Vision 2035 framework, the future strategy defined by President Ismaïl Omar Guelleh. And a plan that builds on the country’s strengths, on its will to emerge and modernize, in line with the demands of our time. In a complex region, Djibouti is working to consolidate its status as a pole of stability, security, and dev… Continue reading “Djibouti launch final implementation of National Development Plan for 2020-2024: “Djibouti ICI””

February 17, 2022

Oblon Selects Anaqua’s AQX Law Firm Platform to Deliver Enhanced IP Management Services to Clients

Anaqua to provide full-service IP law firm with intellectual asset management solutions

BOSTON, Feb. 17, 2022 (GLOBE NEWSWIRE) — Anaqua, the leading provider of innovation and intellectual property management technology, today announced that leading IP law firm Oblon, McClelland, Maier & Neustadt, LLP (Oblon) has selected Anaqua’s AQX Law Firm as their exclusive IP management system for both patents and trademarks.

Oblon is one of the largest law firms in the United States focusing exclusively on intellectual property law and the leader, for decades, among all law firms in filing and obtaining the most patents. The firm selected Anaqua for its integrated technology-based solution, AQX Law Firm, coupled with Anaqua’s team of IP experts and consultative approach.

Daniel Pereira, chair of the Chemical Practice Group at Oblon said: “We work with clients in every field of intellectual property law to obtain, manage and enforce their intellectual property rights. It’s essential we have accurate up-to-date information on our clients’ patent and trademark portfolios and the IP landscape of their respective industries. Anaqua’s AQX platform, consultative approach and team of professionals ensure we have this information at our fingertips to serve and advise our clients, efficiently and effectively.”

Recently, Anaqua expanded the AQX Law Firm platform capabilities through the acquisitions of API-based connectivity software provider SeeUnity, leading cost estimation tool Global IP Estimator^®, and tech-enabled foreign filing solution Actio IP. Oblon will have the ability to leverage this fully integrated platform to continue strengthening IP operations and delivering exceptional client service in today’s evolving market.

Bob Romeo, CEO of Anaqua, commented: “We are honored to be selected as the IP management solutions provider for one of the premier firms specializing in intellectual property law. It’s rewarding to see that our commitment to continually enhancing an intelligent platform with integrated services – one that drives increased efficiency and improved data through automation – was a key differentiator to Oblon. Our expanding presence in the law firm space is a testament to this success in delivering integrated capabilities firms rely on to optimize their internal IP operations while helping clients unlock the full value of their IP. We look forward to working alongside Oblon to empower the firm to efficiently deliver all of their clients’ IP management needs.”

About Anaqua
Anaqua, Inc. is a premium provider of integrated intellectual property (IP) management technology solutions and services. Anaqua’s AQX platform combines best practice workflows with big data analytics and tech-enabled services to create an intelligent environment designed to inform IP strategy, enable IP decision-making, and streamline IP operations. Today, nearly half of the top 100 U.S. patent filers and global brands, as well as a growing number of law firms worldwide use Anaqua’s solutions. Over one million IP executives, attorneys, paralegals, administrators, and innovators use the platform for their IP management needs. The company’s global operations are headquartered in Boston, with offices across the U.S., Europe, and Asia. For additional information, please visit anaqua.com, or on LinkedIn.

About Oblon
Assisting clients for over 50 years, Oblon is one of the largest intellectual property law firms in the United States. Oblon’s professionals provide a full range of intellectual property services to some of the world’s leading innovators. Oblon is headquartered in Alexandria, Virginia within steps of the United States Patent and Trademark Office with an affiliate office in Tokyo, Japan. Visit oblon.com for more information on the firm.

Company Contact:
Amanda Hollis
Associate Director, Communications
Anaqua
617-375-2626
ahollis@Anaqua.com

February 17, 2022

Oblon choisit la plateforme AQX pour cabinets conseils d’Anaqua pour offrir de meilleurs services de gestion de la propriété intellectuelle à ses clients

Anaqua fournit des solutions de gestion d’actifs intellectuels à un cabinet de conseils en propriété intellectuelle

BOSTON, 17 févr. 2022 (GLOBE NEWSWIRE) — Anaqua, le leader des technologies de gestion de l’innovation et de la propriété intellectuelle, annonce aujourd’hui que le cabinet conseils Oblon, McClelland, Maier & Neustadt, LLP (Oblon) a choisi AQX Law Firm d’Anaqua comme système exclusif de gestion de la propriété intellectuelle pour les brevets et les marques.

Oblon est l’un des plus grands cabinets conseils aux États-Unis exclusivement dédié au droit de la propriété intellectuelle. Depuis plusieurs dizaines d’années, Oblon est le premier cabinet conseils déposant et obtenant le plus de brevets. Le cabinet a choisi Anaqua pour sa solution technique complète, AQX Law Firm, ainsi que l’expertise de l’équipe de consultants d’Anaqua en matière de PI.

Daniel Pereira, président du Chemical Practice Group chez Oblon, a déclaré : “Nous travaillons avec des clients dans tous les domaines du droit de la propriété intellectuelle pour obtenir, gérer et faire respecter leurs droits de propriété intellectuelle. Il est essentiel que nous ayons des informations précises et à jour sur les portefeuilles de brevets et de marques de nos clients et sur le paysage de la propriété intellectuelle de leurs industries respectives. La plateforme AQX d’Anaqua et son équipe de consultants nous assurent d’avoir ces informations à portée de main pour servir et conseiller nos clients, de manière efficace et concrète.”

Récemment, Anaqua a étendu les capacités de la plateforme AQX Law Firm par l’acquisition du fournisseur SeeUnity qui offre des solutions d’interfacage entre logiciels basé sur l’API, de l’outil d’estimation des coûts Global IP Estimator^®, et de la solution de dépôt à l’étranger Actio IP. Oblon aura la possibilité de s’appuyer sur cette plateforme complète pour continuer à renforcer ses activités de PI et fournir un service client exceptionnel dans un marché en constante évolution.

Bob Romeo, PDG d’Anaqua, a commenté : “Nous sommes honorés d’avoir été sélectionné comme fournisseur de solutions de gestion de la propriété intellectuelle pour l’un des premiers cabinets spécialisés dans le droit de la propriété intellectuelle. C’est gratifiant de voir que notre capacité à intégrer continuellement de nouveaux services dans notre plateforme a été un facteur clé de différenciation pour Oblon. C’est une plateforme intelligente qui permet d’augmenter l’efficacité et d’améliorer la qualité des données grâce à l’automatisation. Notre succès croissant auprès des cabinets conseils prouvre notre capacité à fournir des solutions complètes sur lesquelles les cabinets peuvent compter. Ils peuvent ainsi optimiser leurs opérations internes en matière de propriété intellectuelle, tout en aidant leurs clients à tirer le plein potentiel de leur propriété intellectuelle. Nous sommes impatients de travailler aux côtés d’Oblon pour permettre au cabinet de répondre efficacement à tous les besoins de ses clients en matière de gestion de la propriété intellectuelle.”

A propos d’Anaqua
Anaqua, Inc. est un fournisseur de premier plan de solutions et services technologiques intégrés de gestion de la propriété intellectuelle (PI). La plateforme AQX d’Anaqua combine les meilleures pratiques de flux de travail avec des analyses de données et des services technologiques pour créer un environnement intelligent conçu pour définir une stratégie avisée, permettre une meilleure prise de décision et rationaliser les opérations en matière de propriété intellectuelle. Aujourd’hui, près de la moitié des 100 premiers déposants de brevets américains et des marques mondiales, ainsi qu’un nombre croissant de cabinets conseils dans le monde utilisent les solutions Anaqua. Plus d’un million de cadres, d’avocats, de parajuristes, de gestionnaires et d’innovateurs utilisent la plateforme pour leurs besoins de gestion de la PI. Les opérations globales de la société sont basées à Boston, avec des bureaux aux Etats-Unis, en Europe et en Asie. Pour de plus amples informations, veuillez consulter le site anaqua.com, ou LinkedIn.

A propos d’Oblon
Assistant ses clients depuis plus de 50 ans, Oblon est l’un des plus grands cabinets conseils spécialisés dans la propriété intellectuelle aux États-Unis. Les professionnels d’Oblon fournissent une gamme complète de services de propriété intellectuelle à certains des plus grands innovateurs du monde. Oblon a son siège à Alexandria, en Virginie, à quelques pas de l’Office des brevets et des marques des États-Unis, et possède un bureau affilié à Tokyo, au Japon. Visitez oblon.com pour plus d’informations sur le cabinet.

Contact :
Amanda Hollis
Associate Director, Communications
Anaqua
+1-617-375-2626
ahollis@Anaqua.com

February 17, 2022

Seegene Announces Q4 and Full-Year 2021 Financial Results

Total sales of 2021 stood at KRW 1.37 trillion, a 22% increase YoY
Q4 Revenue of KRW 410 billion, up 34% QoQ
Operating profit held steady YoY at KRW 666.7 billion despite its tripled strategic investments in R&D
Seegene to make a strategic shift to a ‘molecular diagnostics(MDx) platform company’ and strengthen its product portfolio to meet market demand

SEOUL, South Korea, Feb. 17, 2022 /PRNewswire/ — Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today announced full-year 2021 financial results that marked an all-time high record with total sales increasing 22% year-over-year (YoY) to KRW 1.37 trillion (approx. US$1.14 billion). Operating profit held steady YoY at KRW 666.7 billion (approx. US$556 million).

Seegene’s record-high sales were supported by growth in both SARS-CoV-2 product sales and its broader molecular diagnostics portfolio. With a subsequent resurgence of COVID-19 cases after the emergence of the Omicron variant in the fourth quarter of 2021, flu cases began to surge as well during the winter season. This had led to an increase in sales of syndromic assays that can simultaneously identify COVID-19 and other respiratory viruses in a single test.

As a result, Seegene’s the total sales in Q4 reached KRW 410 billion (approx. US$342 million), exceeding market estimates by 7%. Its operating profit outperformed expectations by 9%, finishing the quarter at KRW 199.9 billion (approx. US$166 million). Since last December, Seegene has exported 2.8 million tests to five European nations, 5.1 million tests to Israel, and another four million tests to Brazil.

In addition, sales of Seegene’s non-COVID products further strengthened in Q4. Sales of non-COVID products including other respiratory, HPV and STI assays increased by 33% YoY, showing a robust growth.

The company’s operating profit of KRW 666.7 billion (approx. US$556 million) remained unchanged YoY, while the company increased strategic investment in R&D and human resources. Seegene executed a KRW 75 billion (approx. US$62.6 million) investment in R&D – a three-fold increase from 2020 – adding talented employees from various fields including biology and Information Technology, doubling the employee count in 2021 to approximately 1,100 global team members. Also Seegene expanded the instrument portfolio of company’s own and began to internalize the production of core raw materials including extraction reagent and oligonucleotide and enzymes.

Because of such strategic investments, Seegene is set to transform its assay development process from manual to digital, empowering biology experts around the world to develop their own diagnostic assays. By doing so, Seegene will expand its product portfolio ranging from COVID related assays to non-COVID assays including plants, food, and animals. Indeed in 2021, Seegene had successfully developed indigenous technologies for assay ingredients and enhanced its PCR instruments which will be the foundation for the company’s platform business. The company has previously announced plans to provide a standardized tool for development as it makes a strategic shift to a molecular diagnostics(MDx) platform company, which is a part of the company’s platform strategy.

“Today, fast, accurate and large-scale testing is becoming unprecedentedly crucial to fight against the ever-changing pandemic landscape. Seegene will continue to introduce the best solution that meets the market demand,” said Thomas Bum-Joon Kim, Seegene Chief Management Officer. “We will support mass-testing at public-use facilities such as airports, schools and stadiums by mobilizing our fully automated MDx system, AIOS and movable laboratory MOBILE STATION along with our new diagnostic tests. In addition, we will put more emphasis on expanding our syndromic assay portfolio as well as non-COVID products such as HPV, STI and other diseases to prepare for the endemic era. Our goal is to establish sustainable growth by continuing to build a solid foundation for our future, while transforming the company into an MDx platform company.”

About Seegene, Inc.

Seegene, Inc. was founded in Seoul, South Korea in 2000 and has subsidiaries in the U.S.A., Canada, Germany, Italy, Mexico, Brazil, Colombia, and the Middle East. Seegene, Inc. is an in-vitro diagnostics (IVD) company that has been turning innovative technologies into products through its pioneering R&D activities. Seegene owns its original patent technology including DPO™ (Dual Priming Oligonucleotide) for multiple target amplification; TOCE™ for multiple target detection in a single channel; MuDT™, the world’s first real-time PCR technology that provides individual Ct values for multiple targets in a single channel for quantitative assays.; and mTOCE™ multiplex mutation detection technology. With these cutting-edge molecular diagnostic (MDx) technologies applied to diagnostic kits and other tools, Seegene has enhanced the sensitivity, specificity, and disease-coverage per a test of PCR (polymerase chain reaction) to unprecedented levels by providing accurate high-multiplex PCR products that target and detect genes of multiple pathogens simultaneously per each fluorescence channel. This feature dramatically saves testing time and cost. Seegene continues to set new standards in MDx through cutting-edge innovations.

Logo – https://mma.prnewswire.com/media/1357790/Seegene_logo_Logo.jpg

February 17, 2022

Amii invites the world to AI Week with $100,000 in travel bursaries

Researchers and applied AI experts are invited to explore Edmonton in May 2022

EDMONTON, Alberta, Feb. 17, 2022 (GLOBE NEWSWIRE) — In anticipation of AI Week, May 24 – 27, 2022, the Alberta Machine Intelligence Institute (Amii) announced the first $100,000 in travel bursaries for emerging researchers and applied artificial intelligence (AI) professionals globally. The Global Talent Bursary program will facilitate upwards of 500 guests to attend AI Week in Edmonton, Alberta, Canada. For more information and to apply, head over to www.ai-week.ca/talent-bursaries.

“As we prepare to celebrate 20 years of AI research excellence, I’m thrilled to have the opportunity to invite the world to AI Week. The Global Talent Bursary program makes it financially viable for more of our peers, alumni and collaborators to come to the conference. It also provides amazing access to our rich community to plan future endeavours. I hope you’ll apply and come to AI Week to find your next role, learn more about a dynamic research domain, and find collaborators for startup ventures,” says Cam Linke, CEO of Amii.

Global Talent Bursary recipients receive exclusive access to events at AI Week including an Academic Symposium featuring content from Amii’s deep well of world-leading researchers, a VIP Career Mixer and more. In addition, Amii is pleased to offer Global Talent Bursaries for individuals from groups who are typically underrepresented in Science, Technology, Engineering and Math (STEM) fields, recent immigrants to Canada and individuals from rural communities. Applications are completed on the basis of self-identification.

Recipients will also enjoy access to a special AI Week lecture from Richard S. Sutton, Chief Scientific Advisor, Fellow and Canada CIFAR AI Chair at Amii. One of the world-leaders in the field of reinforcement learning, Dr. Sutton is a Distinguished Research Scientist at DeepMind and one of the world’s foremost thinkers about AI, the mind and what it means to be intelligent.

“I invite you to join us for four days of workshops, social events, educational events – experts and students, meeting each other and seeing the Edmonton ecosystem. We have travel bursaries available for early-career researchers of all types, and we’re excited to meet people and learn a little bit about AI together,” says Sutton.

The inaugural AI Week presented by Amii is a four-day celebration of Alberta’s 20-year history of excellence in AI and machine learning. The event will run from May 24-27, 2022 in Edmonton with a mix of in-person, hybrid and digital first offerings. With programming for all audiences, the event marks Amii’s 5th anniversary and the 20th anniversary of the founding of the Amii research centre at the University of Alberta. For updates and announcements, join the AI Week Insiders List at www.ai-week.ca.

The celebration will feature a variety of events and programming focused around AI and machine learning. Audiences of all ages will have an opportunity to connect with AI leaders in research and industry, explore the promise and possibilities of the technology and immerse themselves in the science of AI and machine learning. With something for experts and beginners alike, events and activations include:

Keynotes, presentations and informal talks for a range of knowledge levels
Academic symposium highlighting Alberta’s AI research excellence
AI talent mixer connecting job seekers with potential employers
K-12 sessions exploring future careers in AI
Community events series organized by partner organizations
Socials, mixers, networking events, and more

AI Week presented by Amii will take place from May 24 to 27, 2022 at a range of venues across Edmonton. This year will mark the inaugural year of what will become an annual celebration of Alberta’s AI community. Stay up-to-date on announcements and programming by joining the AI Week Insiders List at www.ai-week.ca.

About Amii

One of Canada’s three centres of AI excellence as part of the Pan-Canadian AI Strategy, Amii (the Alberta Machine Intelligence Institute) is an Alberta-based non-profit institute that supports world-leading research in artificial intelligence and machine learning and translates scientific advancement into industry adoption. Amii grows AI capabilities through advancing leading-edge research, delivering exceptional educational offerings and providing business advice – all with the goal of building in-house AI capabilities. For more information, visit amii.ca.

Spencer Murray
Communications & Public Relations
t: 587.415.6100 ext. 109 | c: 780.991.7136
spencer.murray@amii.ca